MD20150101A2 - Săruri de hidroclorură a unui compus antibiotic - Google Patents

Săruri de hidroclorură a unui compus antibiotic Download PDF

Info

Publication number
MD20150101A2
MD20150101A2 MDA20150101A MD20150101A MD20150101A2 MD 20150101 A2 MD20150101 A2 MD 20150101A2 MD A20150101 A MDA20150101 A MD A20150101A MD 20150101 A MD20150101 A MD 20150101A MD 20150101 A2 MD20150101 A2 MD 20150101A2
Authority
MD
Moldova
Prior art keywords
hydrochloride salts
antibiotic compound
compounds
compound
relates
Prior art date
Application number
MDA20150101A
Other languages
English (en)
Russian (ru)
Other versions
MD4599B1 (ro
MD4599C1 (ro
Inventor
Вэйцзян ЧЖАН
Ронни ЧЭУН
Димитар Филипов
Джек ГРИН
Цзюньнин Ли
Original Assignee
Theravance Biopharma Antibiotics Ip, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma Antibiotics Ip, Llc filed Critical Theravance Biopharma Antibiotics Ip, Llc
Publication of MD20150101A2 publication Critical patent/MD20150101A2/ro
Publication of MD4599B1 publication Critical patent/MD4599B1/ro
Publication of MD4599C1 publication Critical patent/MD4599C1/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Invenţia se referă la un compus cu formula I:,în care x se află în intervalul de la aproximativ 1 până la aproximativ 2. Invenţia se referă, de asemenea, la compoziţii farmaceutice cu conţinut de astfel de compuşi, la procedee de obţinere şi la metode de utilizare a unor astfel de compuşi, de exemplu, în tratamentul infecţiei bacteriene.
MDA20150101A 2013-03-13 2014-03-06 Săruri de hidroclorură a unui compus antibiotic MD4599C1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361779065P 2013-03-13 2013-03-13
PCT/US2014/021064 WO2014158952A1 (en) 2013-03-13 2014-03-06 Hydrochloride salts of an antibiotic compound

Publications (3)

Publication Number Publication Date
MD20150101A2 true MD20150101A2 (ro) 2016-02-29
MD4599B1 MD4599B1 (ro) 2018-11-30
MD4599C1 MD4599C1 (ro) 2019-06-30

Family

ID=50483481

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150101A MD4599C1 (ro) 2013-03-13 2014-03-06 Săruri de hidroclorură a unui compus antibiotic

Country Status (32)

Country Link
US (1) US9161990B2 (ro)
EP (1) EP2968446B1 (ro)
JP (3) JP6482523B2 (ro)
KR (1) KR20150126659A (ro)
CN (1) CN105120883B (ro)
AR (1) AR095044A1 (ro)
AU (1) AU2014241481B9 (ro)
BR (1) BR112015022716A2 (ro)
CA (1) CA2902720A1 (ro)
CY (1) CY1119316T1 (ro)
DK (1) DK2968446T3 (ro)
EA (1) EA027282B1 (ro)
ES (1) ES2633964T3 (ro)
GE (2) GEP20186874B (ro)
HR (1) HRP20171188T1 (ro)
HU (1) HUE033738T2 (ro)
IL (1) IL240663A0 (ro)
LT (1) LT2968446T (ro)
MD (1) MD4599C1 (ro)
ME (1) ME02854B (ro)
MX (1) MX361984B (ro)
PH (1) PH12015502060A1 (ro)
PL (1) PL2968446T3 (ro)
PT (1) PT2968446T (ro)
RS (1) RS56141B1 (ro)
SG (1) SG11201507235YA (ro)
SI (1) SI2968446T1 (ro)
SM (1) SMT201700369T1 (ro)
TW (1) TWI608845B (ro)
UA (1) UA115086C2 (ro)
WO (1) WO2014158952A1 (ro)
ZA (1) ZA201506748B (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3274327B1 (en) * 2015-03-24 2021-05-05 Wilmar Trading Pte Ltd Polyol esters of metathesized fatty acids and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434287A (en) * 1975-02-20 1984-02-28 Ciba-Geigy Corporation Cephalosporin derivatives
AR229883A1 (es) 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4626534A (en) 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
DE3801179A1 (de) 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
JPH0331449A (ja) 1989-06-27 1991-02-12 Yamaha Corp リードフレーム用Fe―Ni合金
JP3129428B2 (ja) 1989-09-30 2001-01-29 エーザイ株式会社 セファロスポリン系薬物を含有する注射用組成物
JPH03193735A (ja) 1989-12-22 1991-08-23 Shionogi & Co Ltd グリコペプチド系抗生物質の安定化組成物
JP4142149B2 (ja) 1997-07-10 2008-08-27 明治製菓株式会社 バンコマイシンの凍結乾燥製剤
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
EP1618114B1 (en) * 2003-04-16 2010-07-14 Sandoz AG Processes for the preparations of cefepime
DE602004024393D1 (de) 2003-05-23 2010-01-14 Theravance Inc Quervernetzte glycopeptid-cephalosporin-antibiotika
US6878868B2 (en) 2003-06-24 2005-04-12 Mcmillan Stacy L. Portable high-hat device
US7067482B2 (en) 2003-07-11 2006-06-27 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
TWI342312B (en) 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
US20080103121A1 (en) 2006-10-30 2008-05-01 Gole Dilip J Cephalosporin derivative formulation
FR2932177B1 (fr) 2008-06-06 2012-11-30 Inst Francais Du Petrole Procede d'hydrogenation selective sur un catalyseur contenant de l'or.
JP2010105965A (ja) 2008-10-30 2010-05-13 Taiyo Yakuhin Kogyo Kk バンコマイシン製剤
US8431539B2 (en) 2009-09-17 2013-04-30 Eagle Pharmaceuticals, Inc. Formulations of daptomycin
JP2013511522A (ja) 2009-11-23 2013-04-04 イーグル・ファーマシューティカルズ・インコーポレーテッド ダプトマイシン製剤

Also Published As

Publication number Publication date
TWI608845B (zh) 2017-12-21
EA027282B1 (ru) 2017-07-31
EP2968446B1 (en) 2017-05-03
HK1214524A1 (en) 2016-07-29
AR095044A1 (es) 2015-09-16
US9161990B2 (en) 2015-10-20
CN105120883B (zh) 2017-11-17
SG11201507235YA (en) 2015-10-29
PL2968446T3 (pl) 2017-11-30
AU2014241481B2 (en) 2018-02-01
WO2014158952A1 (en) 2014-10-02
DK2968446T3 (en) 2017-08-28
AU2014241481B9 (en) 2018-02-15
CY1119316T1 (el) 2018-02-14
HRP20171188T1 (hr) 2017-10-06
AU2014241481A1 (en) 2015-10-01
CN105120883A (zh) 2015-12-02
ES2633964T3 (es) 2017-09-26
EA201591697A1 (ru) 2016-02-29
GEP20186874B (en) 2018-06-25
KR20150126659A (ko) 2015-11-12
HUE033738T2 (hu) 2018-01-29
PH12015502060A1 (en) 2016-01-25
ME02854B (me) 2018-04-20
GEAP201813957A (en) 2018-01-25
MX2015012170A (es) 2015-11-30
CA2902720A1 (en) 2014-10-02
EP2968446A1 (en) 2016-01-20
SI2968446T1 (sl) 2017-08-31
US20140274877A1 (en) 2014-09-18
LT2968446T (lt) 2017-07-25
UA115086C2 (uk) 2017-09-11
JP2017082016A (ja) 2017-05-18
PT2968446T (pt) 2017-07-27
MD4599B1 (ro) 2018-11-30
JP2018177817A (ja) 2018-11-15
MD4599C1 (ro) 2019-06-30
ZA201506748B (en) 2017-08-30
MX361984B (es) 2018-12-19
IL240663A0 (en) 2015-10-29
SMT201700369T1 (it) 2017-09-07
TW201444572A (zh) 2014-12-01
JP2016513642A (ja) 2016-05-16
JP6482523B2 (ja) 2019-03-13
BR112015022716A2 (pt) 2017-07-18
RS56141B1 (sr) 2017-10-31

Similar Documents

Publication Publication Date Title
MD4820B1 (ro) Compuşi dihidroizochinolinonici substituiţi
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
MX381417B (es) Inhibidores de glucosidasa.
MX380239B (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona.
EA201500544A1 (ru) НОВЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ АГЕНТОВ И ИНГИБИТОРОВ β-ЛАКТАМАЗ
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
TN2019000204A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
PH12014502396B1 (en) Nitrogenated heterocyclic compound
MY197698A (en) Oxysterols and methods of use thereof
MX375153B (es) Compuestos antihelminticos.
GEP20227353B (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
BR112016016853A2 (pt) Compostos contendo nitrogênio, seu uso e seu processo de preparação, composição farmacêutica e seu uso
EA201490435A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные пиперидинилом
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
EA201992370A1 (ru) Соединения и способы для лечения бактериальных инфекций
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
PH12016502568B1 (en) Novel heterocyclic compound
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
MD20160111A2 (ro) Derivaţi diheterociclici legaţi de cicloalchil
EA201590331A1 (ru) Новые антибактериальные соединения
MX2015015251A (es) Derivados de la quinolona.
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds

Legal Events

Date Code Title Description
FG4A Patent for invention issued